Moreover, CDCP1 was found to be a novel tumor-associated antigen in EVs from irradiated tumor cells, which can trigger antitumor immunity against primary tumors and experimental lung metastases by enhancing the infiltration of CD8+ and CD4+ T cells [53]. This evidence concerns the gene CD8A and neoplasm.